Min Xue, Ph.D. - Publications

Affiliations: 
University of California, Riverside, Riverside, CA, United States 
 2013 Chemistry 0153 University of California, Los Angeles, Los Angeles, CA 
Area:
Single-cell analysis, Bioanalytical methods, Protein mimetics, Nanomedicine
Website:
https://www.xuelab.org/single-cell-metabolic-assays-1

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Cheng H, Tang Y, Li Z, Guo Z, Heath JR, Xue M, Wei W. Non-Mass Spectrometric Targeted Single-Cell Metabolomics. Trends in Analytical Chemistry : Trac. 168. PMID 37840599 DOI: 10.1016/j.trac.2023.117300  0.485
2021 Cheng H, Li Z, Guo Z, Shao S, Mo L, Wei W, Xue M. Single-cell profiling of D-2-hydroxyglutarate using surface-immobilized resazurin analogs. Biosensors & Bioelectronics. 190: 113368. PMID 34098361 DOI: 10.1016/j.bios.2021.113368  0.306
2021 Yang L, Yan X, Chen J, Zhan Q, Hua Y, Xu S, Li Z, Wang Z, Dong Y, Zuo D, Xue M, Tang Y, Herschman HR, Lu S, Shi Q, et al. Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33836566 DOI: 10.1073/pnas.2012228118  0.5
2020 Su Y, Ko ME, Cheng H, Zhu R, Xue M, Wang J, Lee JW, Frankiw L, Xu A, Wong S, Robert L, Takata K, Yuan D, Lu Y, Huang S, et al. Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line. Nature Communications. 11: 2345. PMID 32393797 DOI: 10.1038/S41467-020-15956-9  0.764
2019 Li Z, Wang Z, Tang Y, Lu X, Chen J, Dong Y, Wu B, Wang C, Yang L, Guo Z, Xue M, Lu S, Wei W, Shi Q. Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics. Nature Communications. 10: 3856. PMID 31451693 DOI: 10.1038/s41467-019-11808-3  0.551
2018 Li Z, Cheng H, Shao S, Lu X, Li M, Tsang J, Zeng P, Guo Z, Wang S, Nathanson DA, Heath JR, Wei W, Xue M. Surface Immobilization of Redox-Labile Fluorescent Probes Enables Single-Cell Co-Profiling of Aerobic Glycolysis and Oncogenic Protein Signaling Activities. Angewandte Chemie (International Ed. in English). PMID 29992724 DOI: 10.1002/Anie.201803034  0.54
2017 Su Y, Wei W, Robert L, Xue M, Tsoi J, Garcia-Diaz A, Homet Moreno B, Kim J, Ng RH, Lee JW, Koya RC, Comin-Anduix B, Graeber TG, Ribas A, Heath JR. Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance. Proceedings of the National Academy of Sciences of the United States of America. PMID 29229836 DOI: 10.1073/Pnas.1712064115  0.772
2016 Wei W, Shin YS, Xue M, Matsutani T, Masui K, Yang H, Ikegami S, Gu Y, Herrmann K, Johnson D, Ding X, Hwang K, Kim J, Zhou J, Su Y, et al. Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma. Cancer Cell. 29: 563-73. PMID 27070703 DOI: 10.1016/J.Ccell.2016.03.012  0.721
2016 Xue M, Wei W, Su Y, Johnson D, Heath JR. Supramolecular Probes for Assessing Glutamine Uptake Enable Semi-Quantitative Metabolic Models in Single Cells. Journal of the American Chemical Society. PMID 26916347 DOI: 10.1021/Jacs.5B12187  0.776
2015 Li X, Xue M, Raabe OG, Aaron HL, Eisen EA, Evans JE, Hayes FA, Inaga S, Tagmount A, Takeuchi M, Vulpe C, Zink JI, Risbud SH, Pinkerton KE. Aerosol droplet delivery of mesoporous silica nanoparticles: A strategy for respiratory-based therapeutics. Nanomedicine : Nanotechnology, Biology, and Medicine. 11: 1377-85. PMID 25819886 DOI: 10.1016/J.Nano.2015.03.007  0.48
2015 Xue M, Wei W, Su Y, Kim J, Shin YS, Mai WX, Nathanson DA, Heath JR. Chemical methods for the simultaneous quantitation of metabolites and proteins from single cells. Journal of the American Chemical Society. 137: 4066-9. PMID 25789560 DOI: 10.1021/Jacs.5B00944  0.737
2015 Hanafi-Bojd MY, Jaafari MR, Ramezanian N, Xue M, Amin M, Shahtahmassebi N, Malaekeh-Nikouei B. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 89: 248-58. PMID 25511563 DOI: 10.1016/J.Ejpb.2014.12.009  0.398
2015 Yilmaz MD, Xue M, Ambrogio MW, Buyukcakir O, Wu Y, Frasconi M, Chen X, Nassar MS, Stoddart JF, Zink JI. Sugar and pH dual-responsive mesoporous silica nanocontainers based on competitive binding mechanisms. Nanoscale. 7: 1067-72. PMID 25475070 DOI: 10.1039/C4Nr04796F  0.475
2014 Yu J, Zhou J, Sutherland A, Wei W, Shin YS, Xue M, Heath JR. Microfluidics-based single-cell functional proteomics for fundamental and applied biomedical applications. Annual Review of Analytical Chemistry (Palo Alto, Calif.). 7: 275-95. PMID 24896308 DOI: 10.1146/Annurev-Anchem-071213-020323  0.753
2014 Xue M, Zink JI. Probing the Microenvironment in the Confined Pores of Mesoporous Silica Nanoparticles. The Journal of Physical Chemistry Letters. 5: 839-842. PMID 24803992 DOI: 10.1021/Jz402760B  0.475
2014 Xue T, Peng B, Xue M, Zhong X, Chiu CY, Yang S, Qu Y, Ruan L, Jiang S, Dubin S, Kaner RB, Zink JI, Meyerhoff ME, Duan X, Huang Y. Integration of molecular and enzymatic catalysts on graphene for biomimetic generation of antithrombotic species. Nature Communications. 5: 3200. PMID 24518643 DOI: 10.1038/Ncomms4200  0.425
2013 Xue M, Zink JI. An enzymatic chemical amplifier based on mechanized nanoparticles. Journal of the American Chemical Society. 135: 17659-62. PMID 24224766 DOI: 10.1021/Ja4066317  0.482
2013 Meng H, Zhao Y, Dong J, Xue M, Lin YS, Ji Z, Mai WX, Zhang H, Chang CH, Brinker CJ, Zink JI, Nel AE. Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in mice. Acs Nano. 7: 10048-65. PMID 24143858 DOI: 10.1021/Nn404083M  0.542
2013 Dong J, Xue M, Zink JI. Functioning of nanovalves on polymer coated mesoporous silica Nanoparticles. Nanoscale. 5: 10300-6. PMID 24056925 DOI: 10.1039/C3Nr03442A  0.512
2013 Tarn D, Xue M, Zink JI. pH-responsive dual cargo delivery from mesoporous silica nanoparticles with a metal-latched nanogate. Inorganic Chemistry. 52: 2044-9. PMID 23391170 DOI: 10.1021/Ic3024265  0.68
2013 Tarn D, Ashley CE, Xue M, Carnes EC, Zink JI, Brinker CJ. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. Accounts of Chemical Research. 46: 792-801. PMID 23387478 DOI: 10.1021/Ar3000986  0.724
2013 Meng H, Mai WX, Zhang H, Xue M, Xia T, Lin S, Wang X, Zhao Y, Ji Z, Zink JI, Nel AE. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. Acs Nano. 7: 994-1005. PMID 23289892 DOI: 10.1021/Nn3044066  0.552
2012 Meng H, Xue M, Zink JI, Nel AE. Development of Pharmaceutically Adapted Mesoporous Silica Nanoparticles Platform. The Journal of Physical Chemistry Letters. 3: 358-9. PMID 26285851 DOI: 10.1021/Jz300021X  0.475
2012 Xue M, Cao D, Stoddart JF, Zink JI. Size-selective pH-operated megagates on mesoporous silica materials. Nanoscale. 4: 7569-74. PMID 23108219 DOI: 10.1039/C2Nr32170J  0.452
2012 Zhang H, Dunphy DR, Jiang X, Meng H, Sun B, Tarn D, Xue M, Wang X, Lin S, Ji Z, Li R, Garcia FL, Yang J, Kirk ML, Xia T, et al. Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs pyrolytic. Journal of the American Chemical Society. 134: 15790-804. PMID 22924492 DOI: 10.1021/Ja304907C  0.7
2012 Clemens DL, Lee BY, Xue M, Thomas CR, Meng H, Ferris D, Nel AE, Zink JI, Horwitz MA. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Antimicrobial Agents and Chemotherapy. 56: 2535-45. PMID 22354311 DOI: 10.1128/Aac.06049-11  0.523
2012 Meng H, Xue M, Zink JI, Nel AE. Development of pharmaceutically adapted mesoporous silica nanoparticles platform Journal of Physical Chemistry Letters. 3: 358-359. DOI: 10.1021/jz300021x  0.406
2011 Xue M, Zhong X, Shaposhnik Z, Qu Y, Tamanoi F, Duan X, Zink JI. pH-Operated mechanized porous silicon nanoparticles. Journal of the American Chemical Society. 133: 8798-801. PMID 21595466 DOI: 10.1021/Ja201252E  0.511
2011 Meng H, Xue M, Xia T, Ji Z, Tarn DY, Zink JI, Nel AE. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. Acs Nano. 5: 4131-44. PMID 21524062 DOI: 10.1021/Nn200809T  0.715
2011 Zhang H, Xia T, Meng H, Xue M, George S, Ji Z, Wang X, Liu R, Wang M, France B, Rallo R, Damoiseaux R, Cohen Y, Bradley KA, Zink JI, et al. Differential expression of syndecan-1 mediates cationic nanoparticle toxicity in undifferentiated versus differentiated normal human bronchial epithelial cells. Acs Nano. 5: 2756-69. PMID 21366263 DOI: 10.1021/Nn200328M  0.529
2010 Kabehie S, Xue M, Stieg AZ, Liong M, Wang KL, Zink JI. Heteroleptic copper switches. Journal of the American Chemical Society. 132: 15987-96. PMID 20964417 DOI: 10.1021/Ja103937V  0.701
2010 Meng H, Xue M, Xia T, Zhao YL, Tamanoi F, Stoddart JF, Zink JI, Nel AE. Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. Journal of the American Chemical Society. 132: 12690-7. PMID 20718462 DOI: 10.1021/Ja104501A  0.557
Show low-probability matches.